genetics-investing Telo Genomics Announces Non-Brokered Private Placement of Convertible Debentures for up to $1,200,000
genetics-investing Telo Genomics Expands Operations with Relocation of Clinical Laboratories to New, Larger Toronto Facility and Provides Board Update
Acquisition of “Thompson Falls” High-Grade Antimony Project Adjacent to America’s only Antimony Smelter
Valeura Energy: Positioned for Organic Growth and Accretive M&A in Southeast Asia’s Offshore Oil Sector
